Emergent BioSolutions (EBS) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$249.2 million.
- Emergent BioSolutions' Enterprise Value fell 5933.5% to -$249.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$249.2 million, marking a year-over-year decrease of 5933.5%. This contributed to the annual value of -$105.6 million for FY2024, which is 546.11% up from last year.
- According to the latest figures from Q3 2025, Emergent BioSolutions' Enterprise Value is -$249.2 million, which was down 5933.5% from -$271.0 million recorded in Q2 2025.
- In the past 5 years, Emergent BioSolutions' Enterprise Value registered a high of -$71.0 million during Q2 2024, and its lowest value of -$642.6 million during Q4 2022.
- For the 5-year period, Emergent BioSolutions' Enterprise Value averaged around -$287.2 million, with its median value being -$249.2 million (2025).
- In the last 5 years, Emergent BioSolutions' Enterprise Value skyrocketed by 8261.75% in 2023 and then plummeted by 28169.01% in 2025.
- Emergent BioSolutions' Enterprise Value (Quarter) stood at -$576.3 million in 2021, then dropped by 11.5% to -$642.6 million in 2022, then skyrocketed by 82.62% to -$111.7 million in 2023, then grew by 5.46% to -$105.6 million in 2024, then tumbled by 135.98% to -$249.2 million in 2025.
- Its Enterprise Value stands at -$249.2 million for Q3 2025, versus -$271.0 million for Q2 2025 and -$152.8 million for Q1 2025.